• Medicox agreed to sell factory land and buildings in Gyeongsangnam-do for KRW 5.75 billion on Oct. 14, 2026.
• Completion is scheduled for Nov. 13, 2026, with proceeds earmarked for secured debt repayment and working capital.
• The sale is expected to generate a disposal loss of approximately KRW 2.71 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicox Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261015000152), on October 15, 2026, and is solely responsible for the information contained therein.